Coronavirus Vaccine / 7 Hills Pharma - LARVOL DELTA

7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies (GlobeNewswire) - "7 Hills Pharma...announced today it had received broad patent protection...on four patents covering the use of the company’s integrin activators with any therapeutic antibody, any checkpoint inhibitor for immuno-oncology, and any vaccine....The US Food & Drug Administration has approved 7 Hills Pharma’s Investigational New Drug (IND) application for the company’s lead integrin activator, 7HP349, for use with immuno-oncology drugs and vaccines for COVID-19 and influenza. The company expects Phase 1 trials to begin in the fall of 2020."

IND • New P1 trial • Patent • Infectious Disease • Novel Coronavirus Disease